Search results
How to spot the signs and symptoms of throat cancer
The Telegraph via Yahoo News· 2 days agoA lack of public awareness around throat cancer means only 13 per cent of head and neck cancers are currently diagnosed at an early stage ...
GeoVax to Raise Approximately $1.3 Million of Gross Proceeds in Offering Priced At-the-Market
Digital Journal· 15 hours agoGeoVax's lead infectious disease candidate is GEO-CM04S1, a next-generation Covid-19 vaccine targeting high-risk immunocompromised patient populations. Currently in three ...
Earnings call: GeoVax reports progress on key vaccine trials By Investing.com
Investing.com· 2 days agoGeoVax, a biotechnology company focusing on developing vaccines for cancer and infectious diseases,...
What Causes Swollen Lymph Nodes in the Armpit?
Health via Yahoo News· 21 hours agoThe lymph nodes are small glands that are part of the immune system. They may become swollen from infections, autoimmune conditions, medication...
HPV jab stops 90% of cancer cases & could eradicate disease 'in our lifetime'
The US Sun· 2 days agoTHE HPV jab is cutting cases of cervical cancer by 90 per cent, a new study has found. The study,...
GeoVax announces $1.3 million direct offering By Investing.com
Investing.com· 11 hours agoGeoVax Labs, Inc. (NASDAQ:GOVX), a biotechnology company focused on developing vaccines and...
Does AI Really Make Moderna Stock (NASDAQ:MRNA) a Buy?
TipRanks via Yahoo Finance· 4 hours agoHowever, the company is once again on the move — in a good way. The stock is up 68% over the past...
Mayo Clinic Q&A: Tonsil cancer: What is it and how do you prevent it?
Post-Bulletin· 6 days agoDEAR MAYO CLINIC: My brother had lingering hoarseness and a sore throat. When he finally went to the doctor, he was diagnosed with tonsil cancer. Tonsil cancer< ...
GeoVax Reports First Quarter 2024 Financial Results and Provides Business Update
NewMediaWire via Yahoo Finance· 3 days agoPresented data on GEO-CM04S1 at World Vaccine Congress, delineating the unique immune system driven...
Nykode Therapeutics - Quarterly report Q1 2024
Benzinga· 4 days agoOSLO, Norway, May 14, 2024 (GLOBE NEWSWIRE) -- Nykode Therapeutics ASA (OSE: NYKD), a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel immunotherapies, today announced its